(1-D2,1-C-13)-4-[(2R,5S)-2,5-DIHYDRO-2-ISOPROPYL-3,6-DIMETHOXY-5-PYRAZINYL]-BUTYLAMINE
Compound with spectra: 1 NMR
![(1-D2,1-C-13)-4-[(2R,5S)-2,5-DIHYDRO-2-ISOPROPYL-3,6-DIMETHOXY-5-PYRAZINYL]-BUTYLAMINE](/api/compound/JYNLdyBw78d.png?ph=true&h=300&w=458 "(1-D2,1-C-13)-4-[(2R,5S)-2,5-DIHYDRO-2-ISOPROPYL-3,6-DIMETHOXY-5-PYRAZINYL]-BUTYLAMINE")
| SpectraBase Compound ID | JYNLdyBw78d |
|---|---|
| InChI | InChI=1S/C13H25N3O2/c1-9(2)11-13(18-4)15-10(7-5-6-8-14)12(16-11)17-3/h9-11H,5-8,14H2,1-4H3/i8+1D2 |
| InChIKey | ALCFKCQHEMKWLG-QEAGVXKHSA-N |
| Mol Weight | 258.37 g/mol |
| Molecular Formula | C1213CH232H2N3O2 |
| Exact Mass | 258.210585 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1,3-BIS-[(2'R,5'S)-2',5'-DIHYDRO-3',6'-DIMETHOXY-2'-ISOPROPYLPYRAZIN-5'-YL]-PROPANE
1-[(2'R,5'S)-2',5'-DIHYDRO-3',6'-DIMETHOXY-2'-ISOPROPYLPYRAZIN-5'-YL]-3-[(2''R,5''R)-2'',5''-DIHYDRO-3'',6''-DIMETHOXY-2''-ISOPROPYLPYRAZIN-5''-YL]-PROPANE
(2R,5S)-2-(2-bromanylprop-2-enyl)-3,6-dimethoxy-5-propan-2-yl-2,5-dihydropyrazine
(2S,5R)-2,5-Dihydro-3,6-dimethoxy-2-isopropyl-5-( 3'-phenyl-2'-propyn-1'-yl)pyrazine
(3S,6R)-6-BENZYLOXYMETHYL-3-ISOPROPYL-2,5-DIMETHOXY-3,6-DIHYDROPYRAZINE
5-Isopropyl-3,6-dimethoxy-2-(1-nitro-2-propyl)-2,5-dihydro-pyrazine
2-(t-Butyl)-5-[4'-chloro-2'-buten-1'-yl]-2,5-dihydro-3,6-dimethoxypyrazine
(4S,2'R)-2-((2,2-dimethyl-6-methylenecyclohex-1-yl)methyl)-4,5-dihydro-4-(1-methylethyl)oxazole
Bupivacaine (Enol) ME
| Title | Journal or Book | Year |
|---|---|---|
| Enantioselective syntheses of isotopically labelled α-amino acids. Preparation of (ϵ-13C)-L-α-aminoadipic acid and five isotopomers of L-lysine with 13C, 15N and 2H in the δ- and ϵ-positions | Recueil des Travaux Chimiques des Pays-Bas | 2010 |